Novo Nordisk recalls medicine samples following Texas power outages

As drug samples couldn't be cooled down due to the lack of power during the storms in Texas in February, Novo Nordisk is voluntarily recalling nearly 1,500 insulin products.

Photo: Stine Tidsvilde

Novo Nordisk has issued a voluntary recall of 1,468 samles containing insulin products which were stored at the wrong temperatures during the raging winter storms in Texas in February, according to a press release from the firm.

The power outages resulting from the storm meant that the products including Levemir, Tresiba, Fiasp, Novolog and Xultophy could not be stored in proper temperature conditions.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs